128 related articles for article (PubMed ID: 38913587)
1. Cost Analysis of Oral Phenazopyridine vs Intravesical Lidocaine for Preprocedural Analgesia for Intradetrusor OnabotulinumtoxinA Injections.
Kapur A; Jericevic D; Wang R; Stewart L; Siddique M
Urol Pract; 2024 Jun; ():101097UPJ0000000000000628. PubMed ID: 38913587
[TBL] [Abstract][Full Text] [Related]
2. Oral phenazopyridine vs intravesical lidocaine for bladder onabotulinumtoxinA analgesia: a randomized controlled trial.
Stewart LE; Siddique M; Jacobs KM; Raker CA; Sung VW
Am J Obstet Gynecol; 2022 Aug; 227(2):308.e1-308.e8. PubMed ID: 35580634
[TBL] [Abstract][Full Text] [Related]
3. Does the setting for intradetrusor onabotulinumtoxinA injection for management of overactive bladder matter?
Ross JH; Abrams M; Vasavada SP; Mangel JM; Ferrando CA
Indian J Urol; 2024; 40(2):101-106. PubMed ID: 38725899
[TBL] [Abstract][Full Text] [Related]
4. Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder.
DiCarlo-Meacham AM; Dengler KL; Welch EK; Brooks DI; Gruber DD; Osborn DJ; Scarlotta L; Vaccaro CM
Neurourol Urodyn; 2023 Jan; 42(1):366-374. PubMed ID: 36455284
[TBL] [Abstract][Full Text] [Related]
5. Intravesical Instillation of OnabotulinumtoxinA in the Treatment of Refractory Overactive Bladder in Participants with Urinary Incontinence.
Chermansky CJ; Richter HE; Jacoby K; Titanji W; Jenkins B; Geib T; Brucker BM
J Urol; 2022 Oct; 208(4):855-862. PubMed ID: 35830550
[TBL] [Abstract][Full Text] [Related]
6. Treatment Response and Complications after Intradetrusor OnabotulinumtoxinA Injection in Male Patients with Idiopathic Overactive Bladder Syndrome.
Mateu Arrom L; Mayordomo Ferrer O; Sabiote Rubio L; Gutierrez Ruiz C; Martínez Barea V; Palou Redorta J; Errando Smet C
J Urol; 2020 Feb; 203(2):392-397. PubMed ID: 31479408
[TBL] [Abstract][Full Text] [Related]
7. Anatomical location and number of injection sites of intravesical OnabotulinumtoxinA for females with refractory idiopathic overactive bladder: A scoping review.
Kelsey E; Wynn J; Holmes A; McLeod K
Neurourol Urodyn; 2024 Mar; 43(3):553-564. PubMed ID: 38225733
[TBL] [Abstract][Full Text] [Related]
8. Postprocedural Pain Associated With 5 Versus 20 Intradetrusor Injections of onabotulinumtoxinA for Treatment of Overactive Bladder: A Multicenter Randomized Clinical Trial.
Chang ES; Ringel N; Woodburn KL; Tanner JP; Bassaly R; Greene K; Wyman A; Iglesia C
Urogynecology (Phila); 2022 Aug; 28(8):518-525. PubMed ID: 35543540
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection.
Cohen BL; Rivera R; Barboglio P; Gousse A
J Urol; 2007 Mar; 177(3):1006-10; discussion 1010. PubMed ID: 17296397
[TBL] [Abstract][Full Text] [Related]
10. Effects of onabotulinumtoxinA on cardiac function following intradetrusor injections.
Mehnert U; de Kort LM; Wöllner J; Kozomara M; van Koeveringe GA; Kessler TM
Exp Neurol; 2016 Nov; 285(Pt B):167-172. PubMed ID: 27342082
[TBL] [Abstract][Full Text] [Related]
11. Injection site number and outcomes of intradetrusor onabotulinumtoxinA for refractory overactive bladder syndrome: a randomized clinical trial.
Zdroik A; El Haraki A; Smith W; Badlani G; Parker-Autry C; Matthews C
Int Urogynecol J; 2024 Jan; 35(1):119-126. PubMed ID: 37991564
[TBL] [Abstract][Full Text] [Related]
12. Pilot study evaluating the safety of intradetrusor injections of botulinum toxin type A: investigation of generalized spread using single-fiber EMG.
Schnitzler A; Genet F; Durand MC; Roche N; Bensmail D; Chartier-Kastler E; Denys P
Neurourol Urodyn; 2011 Nov; 30(8):1533-7. PubMed ID: 21661038
[TBL] [Abstract][Full Text] [Related]
13. Can Intradetrusor OnabotulinumtoxinA Injections Alter Heart Function in Patients with Cardiac Arrhythmia?
Miotla P; Olejniczak P; Futyma K; Wrobel A; Tomaszewski M; Bogusiewicz M; Wawrysiuk S; Markut-Miotla E; Rechberger T
J Clin Med; 2018 Sep; 7(9):. PubMed ID: 30205603
[TBL] [Abstract][Full Text] [Related]
14. Higher Neural Correlates in Patients with Multiple Sclerosis and Neurogenic Overactive Bladder Following Treatment with Intradetrusor Injection of OnabotulinumtoxinA.
Khavari R; Elias SN; Pande R; Wu KM; Boone TB; Karmonik C
J Urol; 2019 Jan; 201(1):135-140. PubMed ID: 30076906
[TBL] [Abstract][Full Text] [Related]
15. Alkalinized lidocaine solution as a first-line local anesthesia protocol for intradetrusor injection of onabotulinum toxin A: Results from a double-blinded randomized controlled trial.
Pereira E Silva R; Ponte C; Lopes F; Palma Dos Reis J
Neurourol Urodyn; 2020 Nov; 39(8):2471-2479. PubMed ID: 32956506
[TBL] [Abstract][Full Text] [Related]
16. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial.
Nitti VW; Dmochowski R; Herschorn S; Sand P; Thompson C; Nardo C; Yan X; Haag-Molkenteller C;
J Urol; 2017 Feb; 197(2S):S216-S223. PubMed ID: 28012773
[TBL] [Abstract][Full Text] [Related]
17. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.
Nitti VW; Dmochowski R; Herschorn S; Sand P; Thompson C; Nardo C; Yan X; Haag-Molkenteller C;
J Urol; 2013 Jun; 189(6):2186-93. PubMed ID: 23246476
[TBL] [Abstract][Full Text] [Related]
18. Interventions to improve tolerability of local anesthetic intradetrusor Botulinum toxin injections: A systematic review.
Faure Walker N; Macpherson F; Tasleem A; Rampal T
Neurourol Urodyn; 2023 Jan; 42(1):23-32. PubMed ID: 36378811
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of agents used for evaluation of ureteral patency during intraoperative cystoscopy in gynecologic and urogynecologic surgery.
Askew AL; Myers ER; Dieter AA
Am J Obstet Gynecol; 2022 Jan; 226(1):100.e1-100.e6. PubMed ID: 34487702
[TBL] [Abstract][Full Text] [Related]
20. Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial.
Chuang YC; Kaufmann JH; Chancellor DD; Chancellor MB; Kuo HC
J Urol; 2014 Dec; 192(6):1743-9. PubMed ID: 25046622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
